Genetic testing and breast cancer
Although 15% of women with breast cancer have a family
history of the disease, only 5% involve known gene mutations. These mutations
include the ones called BRCA1 and BRCA2 which are linked with breast and ovarian
cancer; 2% of all cases of breast cancer are associated with these mutations.
A Scottish company, Rosgen, has been granted a licence to use American
technology for BRCA testing and you may see some publicity about this the
service. Bearing in mind the low number of cases due to these mutations,
it is important for you to understand the facts.
The place of genetic testing is now clear and direct access to the service is
not appropriate. In order to advise an unaffected close family member, the first
step is to identify whether the mutation is present in the family member with
the disease. Only then can the position be put in to perspective. The British
Association of Surgical Oncology have developed guidelines defining the
categories of risk for breast cancer in women with a family history.
(NHS Executive letter 26/1/00)
First degree relative is mother/sister/daughter
Second degree relative is granddaughter/grandmother/aunt/